Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains

Etheresia Pretorius, Martin J. Page, Lize Engelbrecht, Graham C. Ellis, Douglas B. Kell
  • Cardiovascular Diabetology, November 2017, Springer Science + Business Media
  • DOI: 10.1186/s12933-017-0624-5
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1186/s12933-017-0624-5

The following have contributed to this page: Professor Douglas B Kell